Approaches and Technologies for the Treatment of Diabetes
Diabetes Type 2 is commonly diagnosed on routine screening. High risk factors, also indicate the need for screening, include: older age, obesity, family history of diabetic patient polycystic ovary syndrome; hypertension; dyslipidemia; or known cardiovascular disease.
Following approach is used for screening of diabetes :
- Fasting plasma glucose (FPG) >125 mg/dL (most common test)
- Random plasma glucose ≥200 mg/dL with diabetes symptoms such as polyuria, polydipsia, fatigue, weight loss
- Two hours post-load glucose ≥200 mg/dL on a 75 g oral glucose tolerance test
- HbA1c ≥6.5%.
Novel technology for treatment of diabetes
- Stem Cell Technology
- Gene Therapy
- Monoclonal Antibody
- Telemedicine
- Artificial pancreas
- Bariatric surgery versus conventional therapy
- Challenges in the selection of innovation into Diabetes
- Bio- stator:closed loop system
- Artificial Pancreas and Encapsulation
Related Conference of Approaches and Technologies for the Treatment of Diabetes
September 23-24, 2026
24th Global Conference on Diabetes, Endocrinology and Primary Healthcare
Paris, France
September 28-29, 2026
25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders
Berlin, Germany
November 23-24, 2026
35th International Conference on Clinical Diabetes, Diabetic Medication & Treatment
Amsterdam, Netherlands